- Contract Extended One Year -
LEXINGTON, Mass., Jan. 26 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced that MedAssets Supply Chain Systems has extended its contract to offer IL's critical care portfolio through July 2010. This continues a successful history between the two companies, whose original contract was established in 2002.
The contract covers IL's portfolio of critical care analyzers, reagents, consumables and service, including IL's flagship product, the GEM Premier 4000 analyzer for blood gas, electrolyte and metabolite and integrated CO-Oximetry testing. This analyzer features IL's patented Intelligent Quality Management (iQM), a real-time, automated, quality assurance system that continuously detects, corrects and documents, to assure quality results and compliance, 24/7, regardless of operator or testing location. iQM, coupled with its cartridge-based technology and ease of use, allows the GEM Premier 4000 provide consistent, accurate, lab-quality results throughout the hospital. GEMweb Plus software enables remote access to any networked analyzer for real-time status updates and supervision of remote locations.
In addition to the GEM Premier 4000, IL's contract with MedAssets includes the GEM Premier 3000 critical care analyzer, GEM OPL a portable CO-Oximeter, IL 682 CO-Oximeter. The contract also includes GEMweb Plus data management system and GEMweb software, for remote management of the GEM analyzers.
"We have chosen to extend our relationship with Instrumentation Laboratory so our hospital customers and patients can continue to benefit from their high quality critical care technology. In addition, IL's products offer significant cost-efficiencies to our customers," said Mary Ellen Kimmeth, Senior Vice President, Capital and Laboratory Services, MedAssets Supply Chain Systems.
Instrumentation Laboratory Wins Extended Agreement with MedAssets Supply Chain Systems for Critical Care Portfolio
"We are very pleased that MedAssets has elected to extend our contract," said Brian Durkin, Director of Sales and National Accounts at IL. "In July, we were very proud to receive MedAssets' Platinum Vendor Award, their highest supplier honor. We were recognized for superior achievements in improving customer value, customer satisfaction, continuous growth in purchase volume and advancement of MedAssets' philanthropic efforts and corporate values. Now, we can continue to deliver these benefits to MedAssets' customers."
MedAssets partners with healthcare providers to improve their financial strength by implementing integrated spend management and revenue cycle solutions that help control cost, improve margins and cash flow, increase regulatory compliance, and optimize operational efficiency. MedAssets serves more than 125 health systems, 3,300 hospitals and 30,000 non-acute care healthcare providers. For more information, visit www.medassets.com.
About Instrumentation Laboratory
Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM(R) product offerings, part of the critical care line, include the new GEM Premier(TM) 4000 analyzer with Intelligent Quality Management (iQM(R)), GEM Premier 3000 analyzer, GEM OPL(TM), a portable whole blood CO-Oximeter and the GEM PCL Plus, a portable coagulation analyzer. IL's hemostasis portfolio includes the ACL TOP(R) Family of Hemostasis Testing Systems, fully automated, high-productivity analyzers, including the ACL TOP and the new ACL TOP 500 CTS. IL also offers the ACL ELITE(R) and ELITE PRO, other hemostasis analyzers and the HemosIL(R) line of reagents. IL is based in Lexington, Massachusetts.
The Instrumentation Laboratory logo, GEM, iQM, Premier and OPL are trademarks of Instrumentation Laboratory Company and/or one of its subsidiaries or parent companies, and may be registered in the United States Patent and Trademark Office and in other jurisdictions. All other product names, company names, marks, logos, and symbols are trademarks of their respective owners.
CONTACT: Sally McCraven of Instrumentation Laboratory, +1-781-861-4388,
Web site: http://www.ilus.com/